Skip to main content

Find Clinical Trials

Home
Conditions
Bile Duct Neoplasms

Clinical trial condition

Bile Duct Neoplasms

Explore clinical trials studying Bile Duct Neoplasms. Study availability and eligibility vary by location and protocol.

169 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Bile Duct Neoplasms trial results

Completed

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

NCT00003557

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States

View Trial Details

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

NCT00538850

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
Locations: InSys Therapeutics, Incorporated Chandler, Arizona, United States

View Trial Details

Completed

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

NCT00096083

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +63 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

NCT00363584

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +12 more
Locations: Basildon University Hospital Basildon, England, United Kingdom

Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Cancer Research UK Clinical Trials Unit - Birmingham Birmingham, England, United Kingdom

Royal Bournemouth Hospital Bournemouth, England, United Kingdom

View all 46 locations

View Trial Details

Completed

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

NCT00003427

Conditions: Adenocarcinoma, Anal Cancer, Anus Diseases, +44 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

NCT00033462

Conditions: Adenocarcinoma, Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, +25 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

BCX-1777 in Treating Patients With Refractory Cancer

NCT00073944

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +140 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

NCT00003923

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +17 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details